| |
|
Rita Nahta, Ph.D. |
|
Assistant Professor |
|
| |
|
|
|
|
|
| |
|
|
Emory University School of Medicine |
|
| |
|
|
Emory Winship Cancer Institute, Room 4008 |
|
| |
|
|
1365-C Clifton Road |
|
| |
|
|
Atlanta, GA 30322 |
|
| |
|
|
Tel: 404-778-3097 |
|
| |
|
|
Tel: 404-778-3064 (Lab) |
|
| |
|
|
Fax: 404-727-0365 |
|
| |
|
|
rnahta@emory.edu |
|
| |
|
|
|
|
| |
|
|
Ph.D., Duke University, 2000 |
|
| |
|
|
Postdoctoral Fellow, Harvard Medical School, 2000-2002 |
|
| |
|
|
|
Postdoctoral Fellow, M.D. Anderson Cancer Center, 2002-2004 |
|
| |
|
|
|
Instructor, M.D. Anderson Cancer Center, 2004-2007 |
|
| |
|
|
|
Assistant Professor, Emory University, 2007 |
|
| |
|
Research Interest: |
|
|
|
| |
|
|
|
|
|
| |
|
Diet, obesity, and ER-negative breast cancer (triple negative and HER2-overexpressing). With respect to triple negative breast cancers, we are studying (1) regulation of BRCA1 by dietary polyphenols and dietary carcinogens, (2) biological effects of chemokine secretion and modulation by dietary polyphenols, and (3) the role of IGF-IR signaling in the biology of triple negative breast cancers. In HER2-overexpressing breast cancers, we are studying (1) adipocytokine-mediated resistance to HER2-targeted therapies, and (2) dietary polyphenols and Herceptin resistance. |
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
